Literature DB >> 15195091

Separate domains of AID are required for somatic hypermutation and class-switch recombination.

Reiko Shinkura1, Satomi Ito, Nasim A Begum, Hitoshi Nagaoka, Masamichi Muramatsu, Kazuo Kinoshita, Yoshimasa Sakakibara, Hiroko Hijikata, Tasuku Honjo.   

Abstract

Activation-induced cytidine deaminase (AID) is essential for class-switch recombination (CSR) and somatic hypermutation (SHM). Mutants with changes in the C-terminal region of AID retain SHM but lose CSR activity. Here we describe five mutants with alterations in the N-terminal region of AID that caused selective deficiency in SHM but retained CSR, suggesting that the CSR and SHM activities of AID may dissociate via interaction of CSR- or SHM-specific cofactors with different domains of AID. Unlike cells expressing C-terminal AID mutants, B cells expressing N-terminal AID mutants had mutations in the switch micro region, indicating that such mutations are generated by reactions involved in CSR but not SHM. Thus, we propose that separate domains of AID interact with specific cofactors to regulate these two distinct genetic events in a target-specific way.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15195091     DOI: 10.1038/ni1086

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  81 in total

1.  Histone chaperone Spt6 is required for class switch recombination but not somatic hypermutation.

Authors:  Il-mi Okazaki; Katsuya Okawa; Maki Kobayashi; Kiyotsugu Yoshikawa; Shimpei Kawamoto; Hitoshi Nagaoka; Reiko Shinkura; Yoko Kitawaki; Hisaaki Taniguchi; Tohru Natsume; Shun-Ichiro Iemura; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

2.  AID: a very old motif newly recognized.

Authors:  Amy L Kenter; Palash Bhattacharya
Journal:  Nat Immunol       Date:  2004-12       Impact factor: 25.606

3.  Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes.

Authors:  Lucia Kato; Nasim A Begum; A Maxwell Burroughs; Tomomitsu Doi; Jun Kawai; Carsten O Daub; Takahisa Kawaguchi; Fumihiko Matsuda; Yoshihide Hayashizaki; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 4.  Immunoglobulin class-switch DNA recombination: induction, targeting and beyond.

Authors:  Zhenming Xu; Hong Zan; Egest J Pone; Thach Mai; Paolo Casali
Journal:  Nat Rev Immunol       Date:  2012-06-25       Impact factor: 53.106

Review 5.  Complex regulation and function of activation-induced cytidine deaminase.

Authors:  Janet Stavnezer
Journal:  Trends Immunol       Date:  2011-04-13       Impact factor: 16.687

6.  The cytidine deaminases AID and APOBEC-1 exhibit distinct functional properties in a novel yeast selectable system.

Authors:  Kristina Krause; Kenneth B Marcu; Jobst Greeve
Journal:  Mol Immunol       Date:  2005-06-15       Impact factor: 4.407

Review 7.  The dark side of activation-induced cytidine deaminase: relationship with leukemia and beyond.

Authors:  Kazuo Kinoshita; Taichiro Nonaka
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

8.  Activation-induced deaminase, AID, is catalytically active as a monomer on single-stranded DNA.

Authors:  Sukhdev S Brar; Elizabeth J Sacho; Ingrid Tessmer; Deborah L Croteau; Dorothy A Erie; Marilyn Diaz
Journal:  DNA Repair (Amst)       Date:  2007-09-21

9.  The 9-1-1 DNA clamp is required for immunoglobulin gene conversion.

Authors:  Alihossein Saberi; Makoto Nakahara; Julian E Sale; Koji Kikuchi; Hiroshi Arakawa; Jean-Marie Buerstedde; Kenichi Yamamoto; Shunichi Takeda; Eiichiro Sonoda
Journal:  Mol Cell Biol       Date:  2008-07-28       Impact factor: 4.272

10.  C-terminal region of activation-induced cytidine deaminase (AID) is required for efficient class switch recombination and gene conversion.

Authors:  Somayeh Sabouri; Maki Kobayashi; Nasim A Begum; Jianliang Xu; Kouji Hirota; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.